Germany has long been seen as one of the flourishing life sciences hubs in Europe. With its numerous hotspots – Berlin, Heidelberg, Munich, Mannheim just to name a few – it presents the perfect breeding ground for every young biotech company. But what does it take to become a successful biotech company? How does a brilliant idea create a venture that will change lives? How long does it take to become a success? Questions, that all startups ask themselves at the beginning of their development. In
German Biotech Startups
VEROVACCiNES is fighting infections and widespread use of antibiotics in animal health by using a novel class of combination vaccines.
biotx.ai has the goal of making precision medicine a reality. The team of six have developed an artificial intelligence (AI)
SpinPlant develops innovative collagen nanomaterials for several uses in the field of regenerative medicine. Their products combine the unique characteristics
Mireca Medicines GmbH works hard to prevent people from going blind from rare inherited retinal degeneration. Mireca develops a cGMP analogue
DyNAbind’s mission is to empower researchers with the tools they need to discover and optimize drug candidates for a new
lifespin revolutionizes the use of NMR technology and is working on developing diagnostic and bioanalytical methods, as well as software
BluCon Biotech GmbH provides a unique technology by which L-lactic acid can be produced with the lowest possible production costs.
Assay.Works mission is to accelerate their partner’s research programs by developing and executing predictive and scalable assays to quantify the
The proprietary antisense technology developed by UGISense AG overcomes the drawbacks of standard antisense technologies. Together with industrial partners, they
NUMAFERM is a pioneer in the production of recombinant peptides. By lowering production costs significantly, they are going to make
PreOmics develops and provides innovative technologies for customers around the world from mass spectrometry-based proteomics to support researchers in their
TolerogenixX has a patented technology that can be used to suppress unwanted immune responses in the body. This novel cell therapy
Avergen seeks to find new treatments for cancer. They are establishing a drug discovery platform for protein-to-protein interaction inhibitors. The advantage
Cenata is available as a partner in all matters relating to genetic prenatal diagnosis, non-invasive prenatal testing (NIPT), and interpretation
Cellbricks is a specialist in bioprinting, which allows the three-dimensional printing of biological material. Driven by the vision to advance
This company’s vision is to establish Upcyte Technologies as the gold standard and preferred source of cell-based products for research
Immunic AG develops immune modulators to block TH17, TH1-mediated immune drawbacks, and autoimmune responses. Their main goal is to develop
This company is translating innovative science into successful immunotherapeutic approaches. Heidelberg ImmunoTherapeutics is a clinical stage company dedicated to the
Cardior is developing a proprietary RNA technology to revolutionize heart failure treatment. This company aims to be the international leader
With their Clean Peptide technology, Sulfotools is revolutionizing the over 40-year-old process of chemical peptide synthesis, making it more sustainable and eco-friendly.
This startup is developing next-generation cancer immunotherapies targeting novel immune evasion pathways. iOmx focuses on the development of first-in-class cancer